Metraipolis › archive › dc_d362bd936724

A novel cell-permeable LOXL2 inhibitor PAT-1251 potently suppresses biliary liver fibrosis via collagen crosslinking-dependent and -independent mechanisms — Europe PMC PMID:41385725

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41385725
DOI
10.1097/hc9.0000000000000863
License (as archived)
solo-consultazione
Archived
2026-11-07T16:56:35.886Z
SHA-256 of the archived text
ee769df09c985eb943a5bf7110df6af274fe7f5f40e74b4ac2dce6766301a33c
Stable URL of this page
https://metraipolis.com/documento/dc_d362bd936724

How to cite

A novel cell-permeable LOXL2 inhibitor PAT-1251 potently suppresses biliary liver fibrosis via collagen crosslinking-dependent and -independent mechanisms — Europe PMC PMID:41385725 — Europe PMC (en), https://europepmc.org/article/MED/41385725 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d362bd936724 (Metraipolis archive dc_d362bd936724, sha256 ee769df09c985eb943a5bf7110df6af274fe7f5f40e74b4ac2dce6766301a33c)
BibTeX
@misc{dcd362bd936724,
  title = {A novel cell-permeable LOXL2 inhibitor PAT-1251 potently suppresses biliary liver fibrosis via collagen crosslinking-dependent and -independent mechanisms — Europe PMC PMID:41385725},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41385725},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d362bd936724; sha256 ee769df09c985eb943a5bf7110df6af274fe7f5f40e74b4ac2dce6766301a33c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41385725. Agents can read the archived copy with the MCP tool read_document.